Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4α in rat liver

被引:46
|
作者
Wang, B
Cai, SR
Gao, CH
Sladek, FM
Ponder, KP
机构
[1] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA
[3] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA
关键词
D O I
10.1053/jhep.2001.28885
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The acute-phase response can result in decreased liver-specific functions and death as a result of liver failure. We show here that lipopolysaccharide (LPS), an endotoxin that induces the acute-phase response, results in a marked decrease in the major isoforms of the transcription factor, hepatocyte nuclear factor 4 alpha (HNF-4 alpha), in livers of rats. HNF-4 alpha is a nuclear receptor that is critical for the expression of several liver-specific genes. This decrease in HNF-4 alpha is primarily the result of a posttranscriptional mechanism, because mRNA levels are normal, and there are no major changes in the splicing patterns. This decrease was of functional significance, because expression of a gene that is highly dependent on HNF-4 alpha, HNF-1 alpha, was reduced. Interleukin-1 beta (IL-1 beta) is a cytokine whose levels are increased in vivo in response to LPS. IL-1 beta resulted in a decrease in HNF-4 alpha levels in HepG2 cells. This IL-1 beta -induced decrease was likely caused by degradation via the proteasome, because it was prevented by the addition of the proteasome inhibitor, MG132. We conclude that the decrease in HNF-4 alpha that occurs in vivo after the administration of LPS may be the result of IL-1 beta -induccd degradation, and likely contributes to the liver insufficiency that occurs. IL-1 beta antagonists or proteasome inhibitors might increase HNF-4 alpha protein levels in the acute-phase response, which could result in increased liver function and survival.
引用
收藏
页码:979 / 989
页数:11
相关论文
共 50 条
  • [1] Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer
    Kotulkar, Manasi
    Paine-Cabrera, Diego
    Apte, Udayan
    SEMINARS IN LIVER DISEASE, 2024, 44 (03) : 383 - 393
  • [2] Hepatocyte nuclear factor 4α is a critical factor for the production of complement components in the liver
    Kasano-Camones, Carlos Ichiro
    Yokota, Satomi
    Ohashi, Maiko
    Sakamoto, Noriaki
    Ito, Daichi
    Saito, Yoshifumi
    Uchida, Ryo
    Ninomiya, Kazumi
    Inoue, Yusuke
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2024, 60 (10) : 1174 - 1183
  • [3] The gene for hepatocyte nuclear factor (HNF)-4α is activated by glucocorticoids and glucagon, and repressed by insulin in rat liver
    Oyadomari, S
    Matsuno, F
    Chowdhury, S
    Kimura, T
    Iwase, K
    Araki, E
    Shichiri, M
    Mori, M
    Takiguchi, M
    FEBS LETTERS, 2000, 478 (1-2) : 141 - 146
  • [4] Regression effect of hepatocyte nuclear factor 4 on liver cirrhosis in rats
    Fan, Ting Ting
    Hu, Ping Fang
    Wang, Jian
    Wei, Ji
    Zhang, Qing
    Ning, Bei Fang
    Yin, Chuan
    Zhang, Xin
    Xie, Wei Fen
    Chen, Yue Xiang
    Shi, Bin
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (06) : 318 - 327
  • [5] Hormonal regulation of the hepatocyte nuclear factor-4α gene in liver
    Oyadomari, S
    Kimura, T
    Iwase, K
    Araki, E
    Shichiri, M
    Mori, M
    Takiguchi, M
    DIABETES, 1999, 48 : A200 - A200
  • [6] The expression of hepatocyte nuclear factor 4α and hepatocyte nuclear factor 3β in human tissues
    Long, Yun
    Huang, Feijun
    Tang, Hong
    Liu, Chong
    He, Fang
    Liu, Li
    Zhao, Liansan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A3 - A4
  • [7] Lipopolysaccharide (LPS) but not hepatocyte growth factor (HGF) results in a dramatic decrease in DNA binding activity for members of the CCAAT/enhancer binding protein (C/EBP) family in rat liver in vivo.
    Yu, L
    Gao, CH
    Ponder, KP
    HEPATOLOGY, 1999, 30 (04) : 394A - 394A
  • [8] Hepatocyte Nuclear Factor 4α-Nuclear Factor-κB Feedback Circuit Modulates Liver Cancer Progression
    Ning, Bei-Fang
    Ding, Jin
    Liu, Jiao
    Yin, Chuan
    Xu, Wen-Ping
    Cong, Wen-Ming
    Zhang, Qing
    Chen, Fei
    Han, Tao
    Deng, Xing
    Wang, Pei-Qin
    Jiang, Cai-Feng
    Zhang, Jun-Ping
    Zhang, Xin
    Wang, Hong-Yang
    Xie, Wei-Fen
    HEPATOLOGY, 2014, 60 (05) : 1607 - 1619
  • [9] Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
    Guldiken, Nurdan
    Argemi, Josepmaria
    Gurbuz, Berivan
    Atkinson, Stephen R.
    Oliverius, Martin
    Fila, Petr
    Hamesch, Karim
    Bruns, Tony
    Cabezas, Joaquin
    Lozano, Juan J.
    Mann, Jelena
    Cao, Sheng
    Mathurin, Philippe
    Shah, Vijay H.
    Trautwein, Christian
    Thursz, Mark R.
    Bataller, Ramon
    Strnad, Pavel
    BMC MEDICINE, 2021, 19 (01)
  • [10] Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases
    Yeh, Matthew M.
    Bosch, Dustin E.
    Daoud, Sayed S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (30) : 4074 - 4091